OR51A7

Across TCGA pan-cancer cohorts, OR51A7 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR51A7 data layer compared with 5 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR51A7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR51A7 expression acts as an unfavorable survival marker, although some lineages such as SARC show a favorable association.

ACC, LIHC, and KIRC are the cancer types where OR51A7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.010	0.582	<.001	81	view →
LIHC	OS	Tertile	III,IV	0.059	0.738	<.001	63	view →
KIRC	DFS	Tertile	All	0.706	0.816	.008	40	view →
STAD	OS	Tertile	III,IV	0.416	0.677	.004	36	view →
PCPG	OS	Tertile	All	0.032	0.948	<.001	36	view →
THCA	DFS	Tertile	II,III,IV	0.180	0.793	.008	27	view →
COAD	OS	Tertile	III,IV	0.140	0.792	<.001	27	view →
UCS	DFS	Tertile	II,III,IV	0.140	0.455	.024	18	view →
READ	DFS	Tertile	II,III,IV	0.112	0.800	.002	18	view →
LGG	DFS	Tertile	All	0.353	0.759	.019	9	view →
ESCA	DFS	Tertile	All	0.244	0.771	.042	9	view →
SARC	DFS	Tertile	All	0.844	0.324	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR51A7–ACC (DFS)

Open the ACC breakdown →